Search

Search Constraints

You searched for: Author/Creator Kowdley, K. V.

Search Results

1. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Issue 10 (17th March 2015)

5. Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Issue 5 (10th July 2017)

7. Increased parenchymal damage and steatohepatitis in Caucasian non‐alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Issue 11 (11th October 2016)

8. Increased parenchymal damage and steatohepatitis in Caucasian non‐alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Issue 11 (11th October 2016)

9. Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study. Issue 1 (11th October 2016)

10. Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis. Issue 2 (29th May 2013)